DICE Therapeutics Inc. (DICE)
NASDAQ: DICE
· Real-Time Price · USD
47.55
0.03 (0.06%)
At close: Aug 08, 2023, 10:00 PM
DICE Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -104.24M | -90.94M | -83.89M | -76.86M | -73.64M | -59.48M | -48.96M | -39.89M | -28.57M | -21.21M |
Depreciation & Amortization | 2.52M | 2.53M | 2.42M | 1.97M | 1.52M | 1M | 661K | 677K | 700K | 521K |
Stock-Based Compensation | 17.2M | 15.9M | 12.82M | 11.16M | 10.86M | 7.04M | 5.58M | 4.05M | 1.04M | 646K |
Other Working Capital | 2.01M | 650K | -191K | 2.26M | 3.76M | 1.26M | 2.42M | 606K | -634K | 357K |
Other Non-Cash Items | -4.69M | -1.05M | 1.34M | 1.22M | 2.53M | 1.81M | 1.78M | 1.67M | 301K | 82K |
Deferred Income Tax | n/a | n/a | 329K | 464K | 1.84M | 1.84M | 1.51M | 1.38M | n/a | n/a |
Change in Working Capital | 4.97M | 962K | 2.64M | 1.33M | 3.97M | 3.84M | 1.65M | 3.04M | -113K | 1.28M |
Operating Cash Flow | -84.23M | -72.59M | -64.32M | -60.84M | -54.44M | -45.46M | -39.29M | -30.46M | -26.64M | -18.69M |
Capital Expenditures | -2.99M | -2.05M | -2.24M | -2M | -1.59M | -738K | -718K | -539K | -418K | -382K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -525.43M | -516.08M | -183.86M | -330.75M | -301.63M | -259.89M | -218.47M | -26.97M | -26.96M | -24.08M |
Sales Maturities Of Investments | 298.19M | 271.24M | 228.98M | 134.43M | 60.63M | 32.57M | 14.56M | 2.7M | 3M | 3M |
Other Investing Acitivies | 44.61M | 44.61M | 44.61M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -185.63M | -202.28M | 87.49M | -198.32M | -242.59M | -228.06M | -204.62M | -24.81M | -24.38M | -21.46M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 4.83B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -4.5B | 322.65M | 322.25M | -4.33M | 298.15M | 302.67M | 300.25M | 356.11M | 53.28M | 51.43M |
Financial Cash Flow | 326.56M | 322.65M | 322.25M | -4.33M | 298.15M | 302.67M | 300.25M | 356.11M | 53.28M | 51.43M |
Net Cash Flow | 56.7M | 47.78M | 345.42M | -263.49M | 1.11M | 29.15M | 56.34M | 300.84M | 2.26M | 11.28M |
Free Cash Flow | -87.22M | -74.65M | -66.56M | -62.84M | -56.03M | -46.2M | -40.01M | -31M | -27.06M | -19.07M |